The Integrilin effect evaluation on the P-PCI on mortality and echocardiography in patients suffered from acute MI and the comparison with P-PCI

Trial Profile

The Integrilin effect evaluation on the P-PCI on mortality and echocardiography in patients suffered from acute MI and the comparison with P-PCI

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Eptifibatide (Primary)
  • Indications Myocardial infarction; Thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2014 Status changed from recruiting to completed as per Iranian Registry of Clinical Trials record.
    • 27 Nov 2012 Recruitment expected to complete on the 22nd of December 2013
    • 27 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top